Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01872260
Title Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | CHE | AUS

Facility Status City State Zip Country Details
Univ of California at San Diego Moores Cancer Ctr San Diego California 92103 United States Details
UCSF Medical Center San Francisco California 94143 United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Massachusetts General Hospital SC-5 Boston Massachusetts 02114 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Ctr Nashville Tennessee 37232 United States Details
Texas Oncology Dallas Texas 75246 United States Details
Mays Cancer Ctr Uthsa Mdacc San Antonio Texas 78229 United States Details
Northwest Medical Specialties Tacoma Washington 98405 United States Details
Novartis Investigative Site Westmead New South Wales 2145 Australia Details
Novartis Investigative Site Parkville Victoria 3050 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Paris 10 75475 France Details
Novartis Investigative Site Saint Herblain 44805 France Details
Novartis Investigative Site Pisa PI 56124 Italy Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Bellinzona 6500 Switzerland Details
Novartis Investigative Site Glasgow G12 0YN United Kingdom Details
Novartis Investigative Site Manchester M20 2BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field